Soft Tissue Sarcoma

• FDA approval · 2012-02-17
  FDA Approved: HALAVEN — Supplemental Application (BSP Pharmaceuticals SpA)

  FDA approved a supplemental application for HALAVEN (eribulin mesylate) submitted by BSP Pharmaceuticals SpA.

• FDA approval · 2009-10-19
  FDA Approved: VOTRIENT — Original Application (Novartis Pharmaceuticals Corporation)

  FDA approved VOTRIENT (pazopanib hydrochloride) under an Original Application for cancer indications, marking pazopanib’s initial approval.